Investigating the Natural History of Lung Function Facts, Pitfalls, and Opportunities

被引:27
作者
Kohansal, Robab [1 ,2 ,3 ]
Soriano, Joan B. [1 ,4 ]
Agusti, Alvar [1 ,4 ,5 ]
机构
[1] Fdn Caubet Int Ctr Adv Resp Med CIMERA, Program Epidemiol & Clin Res, Bunyola, Illes Balears, Spain
[2] Otto Wagner Hosp, Dept Pulm & Crit Care Med, Vienna, Austria
[3] Otto Wagner Hosp, Ludwig Boltzmann Inst COPD, Vienna, Austria
[4] Ctr Invest Biomed Red Enfermedades Resp, Illes Balears, Mallorca, Spain
[5] Hosp Univ Son Dureta, Serv Pneumol, Illes Balears, Mallorca, Spain
关键词
COPD; epidemiology; longitudinal study; natural history; OBSTRUCTIVE PULMONARY-DISEASE; CORONARY HEART-DISEASE; RESPIRATORY SYMPTOMS; FOLLOW-UP; COPD; SMOKING; DESIGN; BRONCHODILATOR; RESPONSIVENESS; INTERVENTION;
D O I
10.1378/chest.08-1750
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
COPD is currently defined as a progressive, preventable, and treatable disease that is characterized by an accelerated decline of lung function. However, contrary, to other common chronic conditions like cardiovascular disease or cancer, there are no lifelong population-based studies describing the natural history of lung function and COPD. In this review, we describe the methodology used in population-based studies, both American and European, that have formed the basis of our current understanding of the "natural history," of COPD, including studies with serial pulmonary function testing, which hold potential for further investigations. We highlight the methodological limitations of longitudinal studies and suggest possible solutions. Finally, some characteristics of an "ideal" study on the natural history, of lung function decline are recommended, both in health and disease. (CHEST 2009; 135:1330-1341)
引用
收藏
页码:1330 / 1341
页数:12
相关论文
共 46 条
[1]  
Altose MD, 2000, NEW ENGL J MED, V343, P1902
[2]  
[Anonymous], 1979, AM REV RESPIR DIS, V119, P831
[3]   Smoking and lung function of lung health study participants after 11 years [J].
Anthonisen, NR ;
Connett, JE ;
Murray, RP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (05) :675-679
[4]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[5]  
Appleyard M., 1989, SCAND J SOCIAL MED, V170, P1
[6]   VETERANS ADMINISTRATION LONGITUDINAL STUDY OF HEALTHY AGING [J].
BELL, B ;
ROSE, CL ;
DAMON, A .
GERONTOLOGIST, 1966, 6 (04) :179-+
[7]   THE EUROPEAN-COMMUNITY-RESPIRATORY-HEALTH-SURVEY [J].
BURNEY, PGJ ;
LUCZYNSKA, C ;
CHINN, S ;
JARVIS, D ;
VERMEIRE, P ;
DAHL, R ;
NIELSEN, N ;
MAGNUSSEN, H ;
WICHMANN, H ;
PAPAGEORGIOU, N ;
ANTO, J ;
CAPELASTEGUI, A ;
CASTILLO, J ;
MALDONADO, J ;
MORATALLA, J ;
QUIROS, R ;
BOUSQUET, J ;
NEUKIRCH, F ;
PIN, I ;
TAYTARD, A ;
TECULESCU, D ;
PRICHARD, J ;
BUGIANI, M ;
DEMARCO, R ;
CASCIO, VL ;
RIJCKEN, B ;
AVILA, R ;
LOUREIRO, C ;
MARQUES, A ;
BURR, M ;
HALL, R ;
HARRISON, B ;
STARK, J ;
FLOREY, C ;
POPP, W ;
GISLASON, T ;
GULSVIK, A ;
ACKERMANNLIEBRICH, U ;
LINDHOLM, N ;
BOMAN, G ;
ROSENHALL, L ;
AITKHALED, N ;
ABRAMSON, M ;
MANFREDA, J ;
CHOWGULE, R ;
CRANE, J ;
STEPANOV, I ;
BUIST, S .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (05) :954-960
[8]   Airways responsiveness, wheeze onset, and recurrent asthma episodes in young adolescents - The East Boston childhood respiratory disease cohort [J].
Carey, VJ ;
Weiss, ST ;
Tager, IB ;
Leeder, SR ;
Speizer, FE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (01) :356-361
[9]   THE PO RIVER DELTA EPIDEMIOLOGIC-STUDY OF OBSTRUCTIVE LUNG-DISEASE - SAMPLING METHODS, ENVIRONMENTAL AND POPULATION CHARACTERISTICS [J].
CARROZZI, L ;
GIULIANO, G ;
VIEGI, G ;
PAOLETTI, P ;
DIPEDE, F ;
MAMMINI, U ;
CARMIGNANI, G ;
SARACCI, R ;
GIUTINI, C ;
LEBOWITZ, MD .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1990, 6 (02) :191-200
[10]   Outcomes for COPD pharmacological trials:: from lung function to biomarkers [J].
Cazzola, M. ;
MacNee, W. ;
Martinez, F. J. ;
Rabe, K. F. ;
Franciosi, L. G. ;
Barnes, P. J. ;
Brusasco, V. ;
Burge, P. S. ;
Calverley, P. M. A. ;
Celli, B. R. ;
Jones, P. W. ;
Mahler, D. A. ;
Make, B. ;
Miravitlles, M. ;
Page, C. P. ;
Palange, P. ;
Parr, D. ;
Pistolesi, M. ;
Rennard, S. I. ;
Moelken, M. P. Rutten-Van ;
Stockley, R. ;
Sullivan, S. D. ;
Wedzicha, J. A. ;
Wouters, E. F. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) :416-468